Integer Holdings Corporation Divests Electrochem Business
Integer Holdings Corporation (NYSE: ITGR), a prominent name in the medical device contract development and manufacturing sector, recently closed a significant deal by selling its Electrochem business to Ultralife Corporation for a remarkable $50 million in cash. This strategic divestiture marks a pivotal moment for Integer as it reaffirms its commitment to future growth within the high-demand medical technology space.
Utilizing Sale Proceeds Effectively
The financial outcome of this sale positions Integer to improve its overall stability through debt repayment. By eliminating outstanding liabilities, the company can allocate resources more efficiently towards its core operations, aligning itself with burgeoning medtech markets.
Comments from Leadership
Joseph Dziedzic, the President and CEO of Integer, expressed optimism regarding the future trajectory of the company following the divestiture. “With the divestiture of Electrochem, Integer is now a pure-play medical technology company with additional capital to deploy in high-growth medtech markets,” he stated. He also conveyed gratitude towards the Electrochem team, acknowledging their valuable contributions over the years. Dziedzic expressed confidence that Electrochem would flourish under Ultralife’s ownership.
Integer Holdings: A Leader in Medical Technology
Integer Holdings Corporation stands as one of the world's largest medical device CDMOs, serving a diverse array of sectors including cardiac rhythm management, neuromodulation, and cardiovascular markets. Its dedication to enhancing the quality of life for patients through innovative products is evidenced by its collaborations with various medical device companies and OEMs.
The Company’s Vision
Integer aims to continuously enrich patient lives by focusing on high-quality product development and delivery. The company’s notable brands such as Greatbatch Medical and Lake Region Medical exemplify its commitment to excellence and innovation in the industry. By redirecting its resources into critical and high-growth markets, Integer intends to solidify its position as a leader in medical technology.
Investor and Media Relations Information
For further insights and discussions regarding Integer's latest developments, interested parties can reach out to their Investor or Media Relations teams. Andrew Senn leads the Investor Relations section, while Kelly Butler oversees Media Relations, providing a robust support system for inquiries and information dissemination.
Contact Information
Andrew Senn can be contacted via email at andrew.senn@integer.net or by phone at 763.951.8312. For media inquiries, Kelly Butler is available at kelly.butler@integer.net or 469.731.6617.
Frequently Asked Questions
What is the recent acquisition made by Integer Holdings Corporation?
Integer Holdings recently sold its Electrochem business to Ultralife Corporation for $50 million.
How will Integer use the proceeds from this sale?
The proceeds from the sale will primarily be used to pay down outstanding debt, improving the company's financial stability.
What does the sale mean for Integer's future?
This sale allows Integer to focus solely on the medical technology sector and expand its operations in high-growth medtech markets.
Who is the CEO of Integer Holdings Corporation?
Joseph Dziedzic serves as the President and CEO of Integer Holdings Corporation.
What are the key brands under Integer Holdings?
Integer's notable brands include Greatbatch Medical and Lake Region Medical, highlighting their expertise in innovative medical device solutions.
